Eighty-five percent or more of Ewing sarcoma cases harbor a chimeric fusion between the RNA binding protein EWS and an ETS family transcription factor (most commonly EWS-FLI1), creating a fusion oncogene (t(11;22)(q24;q12)) deemed relevant to tumor pathogenesis [14,15]. The gene discussed is EWSR1; the disease is neoplasm.